Quality, AI Strategy, and Validation in Regulated Life Sciences

Insights and frameworks for consultants, technology vendors, and QA leaders navigating AI in regulated systems.

This newsletter is for professionals building, validating, or governing AI-enabled systems in GxP environments—without compromising compliance, operational integrity, or inspection readiness.

If you work in or advise on:

• GxP software and digital transformation

• Biotech/pharma clinical systems

• Validation, QA, or regulatory leadership

• AI/ML deployment inside regulated workflows

• Pharmacovigilance, R&D, or manufacturing tech

…you’re in the right place.

💡 What to Expect:

• AI validation frameworks (FDA, EU AI Act, GAMP 5, ISO 42001)

• Governance and change control for adaptive and black-box systems

• Strategic alignment across clinical, R&D, and manufacturing use cases

• Audit, sponsor, and due diligence readiness

• Real-world implementation insights—for consultants and internal teams alike

No hype. No vague futurism.

Just pragmatic, risk-aware thinking for professionals who need to move fast, prove compliance, and create lasting value.

Subscribe to get new posts delivered to your inbox—

and join others shaping the future of compliant, auditable AI in life sciences.

📩 Ready to get started?